Receptors, Virus

Displaying 1 - 3 of 3CSV
Naveed, A., Yu, J., Lawson, S., Gao, R., Ni, S., Paulchakrabarti, M., Choudhury, B., Christopher-Hennings, J., Nelson, E., Sheng, Z., Kennedy, M. A., Li, F., & Wang, D. (2024). Receptor binding and immunogenic properties of the receptor binding domain of influenza D virus hemagglutinin-esterase-fusion protein expressed from Escherichia coli. Virology, 597, 110138. https://doi.org/10.1016/j.virol.2024.110138
Publication Date
Wang, Q., Guo, Y., Liu, L., Schwanz, L. T., Li, Z., Nair, M. S., Ho, J., Zhang, R. M., Iketani, S., Yu, J., Huang, Y., Qu, Y., Valdez, R., Lauring, A. S., Huang, Y., Gordon, A., Wang, H. H., Liu, L., & Ho, D. D. (2023). Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike. Nature, 624(7992), 639–644. https://doi.org/10.1038/s41586-023-06750-w
Publication Date
King, H. A. D., Joyce, M. G., Lakhal-Naouar, I., Ahmed, A., Cincotta, C. M., Subra, C., Peachman, K. K., Hack, H. R., Chen, R. E., Thomas, P. V., Chen, W.-H., Sankhala, R. S., Hajduczki, A., Martinez, E. J., Peterson, C. E., Chang, W. C., Choe, M., Smith, C., Headley, J. A., … Bolton, D. L. (2021). Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. Proceedings of the National Academy of Sciences, 118(38). https://doi.org/10.1073/pnas.2106433118
Publication Date